Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Ana Carolina Viegas Carmo

Professor of Biotechnology, Biology and Sciences, UFSCar, Brazil

Title: Cloning, expression and concentration of antiviral protein from the hemolymph of Lonomia obliqua in bacterial system

Biography

Biography: Ana Carolina Viegas Carmo

Abstract

Insect hemolymph studies demonstrated the presence of active principles such as antiviral. The aim of this work was cloning, expression and concentration of the recAVLOEc protein with antiviral activity from L. obliqua hemolymph. For that, a PCR with specific primers for the antiviral protein, based on the sequence previously cloned in bac-to-bac system, was made. Restriction sites were inserted in the primer for connection to the plasmid pET28a. First reaction was performed with the restriction enzyme BamHI, followed by digestion with the enzyme HindIII. After binding insert in the vector, the construction was selected in E. coli BL21 (DE3) pLysS and the cloning was confirmed by sequencing. The protein expression was induced with IPTG (1mM) at 0.7 DO at 37°C for 4h. In order to concentrate the target-protein, precipitation by salting-out method was used. Initially, ultrasound bacterial lysis was performed. After centrifugation (8,000 rpm x 10min), the saturated salt solution (sodium or ammonium sulfate) was added to the supernatant phase of cellular lysate. This solution was maintained for 12h at 4°C until the formation of the precipitate phase. The solubility curve of recAVLOEc was determined by measuring the protein composition of the supernatant phase. The effectiveness of salts as precipitant agents was verified. In addition, antiviral tests were performed and a titration was made with Measles virus infecting VERO cells, in which 24µg recAVLOEc/mL resulted in the viral title 256-fold lower than control.